These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23770405)

  • 1. Glycolipid antigens and autoantibodies in autoimmune neuropathies.
    Willison HJ; Goodyear CS
    Trends Immunol; 2013 Sep; 34(9):453-9. PubMed ID: 23770405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.
    Rinaldi S; Brennan KM; Kalna G; Walgaard C; van Doorn P; Jacobs BC; Yu RK; Mansson JE; Goodyear CS; Willison HJ
    PLoS One; 2013; 8(12):e82337. PubMed ID: 24358172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of antiglycolipid antibodies.
    Baumann N
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):31-40. PubMed ID: 11064824
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiglycolipid antibodies in Guillain-Barré syndrome and autoimmune neuropathies.
    Kusunoki S
    Am J Med Sci; 2000 Apr; 319(4):234-9. PubMed ID: 10768608
    [No Abstract]   [Full Text] [Related]  

  • 5. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
    Komagamine T; Yuki N
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies.
    Goodfellow JA; Willison HJ
    Curr Opin Neurol; 2016 Oct; 29(5):572-80. PubMed ID: 27427992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological study using glycoarray for detecting antibodies to glycolipids and glycolipid complexes in immune-mediated neuropathies.
    Morikawa M; Kuwahara M; Ueno R; Samukawa M; Hamada Y; Kusunoki S
    J Neuroimmunol; 2016 Dec; 301():35-40. PubMed ID: 27836184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular Mimicry and Guillain-Barré Syndrome].
    Yuki N
    Brain Nerve; 2015 Nov; 67(11):1341-6. PubMed ID: 26560949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A family with Campylobacter enteritis: anti-GD1a antibody with/without Guillain-Barré syndrome.
    Hirano M; Kusunoki S; Asai H; Tonomura Y; Morita D; Ueno S
    Neurology; 2003 May; 60(10):1719-20. PubMed ID: 12771281
    [No Abstract]   [Full Text] [Related]  

  • 10. Guillain-barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder.
    Shahrizaila N; Yuki N
    J Biomed Biotechnol; 2011; 2011():829129. PubMed ID: 21197269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoantibodies in Guillain-Barré Syndrome].
    Uchibori A; Chiba A
    Brain Nerve; 2015 Nov; 67(11):1347-57. PubMed ID: 26560950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.
    Ariga T; Yu RK
    J Neurosci Res; 2005 Apr; 80(1):1-17. PubMed ID: 15668908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Guillain-Barré syndrome: a true case of molecular mimicry.
    Ang CW; Jacobs BC; Laman JD
    Trends Immunol; 2004 Feb; 25(2):61-6. PubMed ID: 15102364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoproteomic identification of antigenic candidate Campylobacter jejuni and human peripheral nerve proteins involved in Guillain-Barré syndrome.
    Loshaj-Shala A; Colzani M; Brezovska K; Poceva Panovska A; Suturkova L; Beretta G
    J Neuroimmunol; 2018 Apr; 317():77-83. PubMed ID: 29338928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré Syndrome.
    Kaida K
    Adv Exp Med Biol; 2019; 1190():323-331. PubMed ID: 31760653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options.
    Ebrahim Soltani Z; Rahmani F; Rezaei N
    Eur Cytokine Netw; 2019 Mar; 30(1):1-14. PubMed ID: 31074417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry.
    Kusunoki S; Shiina M; Kanazawa I
    Neurology; 2001 Aug; 57(4):736-8. PubMed ID: 11524496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiglycolipid antibodies in Guillain-Barré and Fisher syndromes: discovery, current status and future perspective.
    Kusunoki S; Willison HJ; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2021 Mar; 92(3):311-318. PubMed ID: 33376111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between autoantibody specificities and peripheral nervous system involvements.
    Jauberteau-Marchan MO
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):41-9. PubMed ID: 11064825
    [No Abstract]   [Full Text] [Related]  

  • 20. Nodal proteins are target antigens in Guillain-Barré syndrome.
    Devaux JJ; Odaka M; Yuki N
    J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.